People with Down syndrome nearly always develop signs of Alzheimer’s as they age. School of Medicine researchers are taking part in a multisite study to understand how Alzheimer’s develops in this population, with a long-term goal of finding ways to prevent or treat the disease.
An international team of researchers led by scientists at the School of Medicine has identified two regions in our DNA — one newly identified and a second that replicates a past finding — that appear to contribute to one’s risk of becoming dependent on marijuana.
Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine to speed the development of treatments for multiple neurodegenerative conditions.
Deanna M. Barch, chair of psychological and brain sciences in Arts & Sciences and the Gregory B. Couch Professor of Psychiatry at the School of Medicine, and Randall J. Bateman, MD, professor of neurology at the School of Medicine and director of the Dominantly Inherited Alzheimer’s Network and Trials Unit, have been elected to the National Academy of Medicine.
A new, international phase 3 clinical trial led by the Washington University School of Medicine and funded by the National Institutes of Health (NIH), will investigate the potential of three drugs to tame a dangerous inflammatory response seen in some COVID-19 patients.
Carlos Ponce, MD, PhD, assistant professor of neuroscience at the School of Medicine, is one of 20 people to receive a 2020 Packard Fellowship for Science and Engineering. Packard fellows are among the nation’s top early-career scientists. Ponce studies how visual recognition works in the brain.
School of Medicine researchers have received an $8.5 million grant to study the role of gut viruses in inflammatory bowel disease. Tools developed in the course of the project could accelerate research into other roles of the virome in health and disease.
A new grant for research at the School of Medicine focuses on brain scans and other markers of Alzheimer’s. The aim is to establish whether early markers of disease in white populations also apply to African Americans.
New research — co-led by Washington University School of Medicine — has identified the most important features of cancer cells’ protein fragments, which can help distinguish the tumor from healthy tissue, enabling researchers to design better immunotherapies, including vaccines.
Researchers at Washington University School of Medicine have received a grant to study the role of brain inflammation in Parkinson’s disease. The project focuses on whether inflammation aids the spread of Parkinson’s damage throughout the brain.
